Betta Pharmaceuticals Co., Ltd.
SHZ: 300558.SZ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Lieming Ding
- Employees
- 1,961
- Headquarters
- Hangzhou, China
- IPO year
- 2016
- Market cap
- CN¥21.6B
- Website
- https://www.bettapharma.com
Loading 300558…
Loading profile data…Frequently asked questions about 300558
What does Betta Pharmaceuticals Co., Ltd. (300558.SZ) do?
Betta Pharmaceuticals Co., Ltd. researches and develops, manufactures, and markets medicines for the treatment of cancer in China. The company offers Icotinib hydrochloride, an oral epidermal growth factor receptor tyrosine kinase inhibitor, which is used to treat non-small-cell lung cancer; and Ensartinib hydrochloride, an anaplastic lymphoma k...
Where does 300558.SZ trade?
Betta Pharmaceuticals Co., Ltd. (300558.SZ) trades on the Shenzhen Stock Exchange.
What sector is 300558.SZ in?
Betta Pharmaceuticals Co., Ltd. (300558.SZ) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Betta Pharmaceuticals Co., Ltd.?
Lieming Ding is the chief executive officer of Betta Pharmaceuticals Co., Ltd. (300558.SZ).
Where is Betta Pharmaceuticals Co., Ltd. headquartered?
Betta Pharmaceuticals Co., Ltd. is headquartered in China.
Does 300558.SZ pay a dividend?
Yes — Betta Pharmaceuticals Co., Ltd. (300558.SZ) paid a trailing twelve-month dividend of CNY 0.20 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 300558.SZ go public?
Betta Pharmaceuticals Co., Ltd. (300558.SZ) completed its initial public offering in 2016.